Topics

AbbVie won’t defend its patent for Kaletra so it can be made available for coronavirus treatment. https://bit.ly/3duZBQZ pic.twitter.com/QKIAnIxpUi

14:13 EDT 26 Mar 2020 | Pharmafile

AbbVie won’t defend its patent for Kaletra so it can be made available for coronavirus treatment. https://bit.ly/3duZBQZ 

Original Article: AbbVie won’t defend its patent for Kaletra so it can be made available for coronavirus treatment. https://bit.ly/3duZBQZ pic.twitter.com/QKIAnIxpUi

NEXT ARTICLE

More From BioPortfolio on "AbbVie won’t defend its patent for Kaletra so it can be made available for coronavirus treatment. https://bit.ly/3duZBQZ pic.twitter.com/QKIAnIxpUi"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...